To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MX1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
565 supporting clones for gene MX1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA944275 Spleen MX1.a 1 to 553 2 to 554   tiling clone, capped   553/553
(100 %)
0 diff
(100 %id)
DA039181 bladder MX1.a 274 to 839 2 to 567   tiling clone, capped   566/566
(100 %)
0 diff
(100 %id)
DB333408 Spleen MX1.a 2262 to 2797 536 to 1   tiling clone,   536/536
(100 %)
4 diff
(99.3 %id)
DB016490 esophageal, tumor tissue MX1.b 1 to 566 2 to 567   tiling clone, capped   566/566
(100 %)
0 diff
(100 %id)
DA603063   MX1.b 6 to 566 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DB164667 thymus MX1.b 7 to 579 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
AU122500 mammary gland MX1.b 11 to 667 2 to 658   capped   657/661
(99 %)
1 diff
(99.9 %id)
DB158614 thymus MX1.b 11 to 604 2 to 595   capped   594/594
(100 %)
0 diff
(100 %id)
DA954358 Spleen MX1.b 71 to 644 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
BP286289 lung MX1.b 72 to 654 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DA699678   MX1.b 78 to 603 2 to 528   capped   527/527
(100 %)
1 diff
(99.9 %id)
DN990038 brain, whole brain MX1.b 99 to 709 6 to 617       612/617
(99 %)
0 diff
(100 %id)
DA738065   MX1.b 263 to 1058 2 to 795   tiling clone, capped   794/794
(100 %)
5 diff
(99.4 %id)
AU148064 mammary gland MX1.b 2350 to 2861 515 to 1   tiling clone,   515/548
(93 %)
12 diff
(97.9 %id)
DB370671   MX1.b 2376 to 2865 491 to 1   tiling clone,   491/518
(94 %)
10 diff
(98.1 %id)
DA714042   MX1.c 1 to 568 2 to 569   capped   568/568
(100 %)
4 diff
(99.3 %id)
DA705452   MX1.c 3 to 489 2 to 489   tiling clone, capped   488/488
(100 %)
1 diff
(99.8 %id)
DB188420 liver, tumor tissue MX1.c 7 to 581 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA959207 Spleen MX1.c 11 to 566 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
BQ722693 sympathetic trunk MX1.c 36 to 893 1 to 864   tiling clone,   864/897
(96 %)
21 diff
(97.7 %id)
DA942926 Spleen MX1.c 42 to 594 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
AU121592 mammary gland MX1.c 43 to 869 2 to 837   tiling clone, capped   836/840
(99 %)
11 diff
(98.7 %id)
DB146232 thymus MX1.c 44 to 565 2 to 523   capped   522/522
(100 %)
0 diff
(100 %id)
AL710866 human skeletal muscle MX1.c 73 to 888 1 to 827   tiling clone,   827/860
(96 %)
17 diff
(98.1 %id)
AU147378 mammary gland MX1.c 2212 to 2745 531 to 1   tiling clone,   531/537
(98 %)
16 diff
(97.1 %id)
AK315465   MX1.d 1 to 2206 7 to 2212 Q297H V379I M582I tiling clone,   2212/2212
(100 %)
7 diff
(99.7 %id)
DA643954   MX1.d 1 to 502 7 to 508   capped   507/507
(100 %)
1 diff
(99.9 %id)
NM_001178046.1   MX1.d 1 to 2661 5 to 2665 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 2665/2665
(100 %)
0 diff
(100 %id)
DA351922 substantia nigra MX1.e 1 to 549 2 to 550   tiling clone, capped   549/549
(100 %)
0 diff
(100 %id)
NM_002462.3   MX1.e 11 to 2975 1 to 2965 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 2965/2965
(100 %)
0 diff
(100 %id)
DA266910 caudate nucleus MX1.e 12 to 559 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
DB173135 kidney, tumor tissue MX1.e 40 to 607 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
DA386487 thalamus MX1.e 49 to 636 2 to 590   capped   589/589
(100 %)
2 diff
(99.7 %id)
DA123351 cerebellum MX1.e 86 to 618 2 to 536   capped   535/535
(100 %)
3 diff
(99.5 %id)
DA442192 tongue, tumor tissue MX1.e 90 to 664 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
DA179935 amygdala MX1.e 91 to 653 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DB245744 uterus, tumor tissue MX1.e 91 to 660 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
DA956302 Spleen MX1.e 94 to 672 2 to 580   capped   579/579
(100 %)
2 diff
(99.7 %id)
DA880081 Prostate MX1.e 112 to 620 2 to 511   capped   510/510
(100 %)
3 diff
(99.5 %id)
DA948964 Spleen MX1.e 118 to 675 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
BM542919 leiomyosarcoma, uterus MX1.e 126 to 967 1 to 843       843/1099
(76 %)
11 diff
(99.0 %id)
BP352876   MX1.e 128 to 710 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BP288529 lung MX1.e 129 to 712 1 to 584       584/584
(100 %)
5 diff
(99.2 %id)
DB143336 thymus MX1.e 130 to 636 2 to 509   capped   508/508
(100 %)
2 diff
(99.7 %id)
BP287917 lung MX1.e 131 to 711 1 to 582       582/582
(100 %)
12 diff
(98.0 %id)
AK225885 colon MX1.e 132 to 2973 1 to 2881 V217D G517Q E518G K519F L520R ... tiling clone, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 2881/2881
(100 %)
36 diff
(98.8 %id)
AU098655   MX1.e 132 to 431 1 to 300       300/300
(100 %)
5 diff
(98.4 %id)
DA921605 small intestine MX1.e 133 to 702 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
DB201623 trachea MX1.e 133 to 717 2 to 586   capped   585/585
(100 %)
3 diff
(99.5 %id)
BP357610 mammary gland MX1.e 134 to 713 1 to 581       581/581
(100 %)
4 diff
(99.4 %id)
DA712677   MX1.e 135 to 713 2 to 582   capped   581/581
(100 %)
3 diff
(99.5 %id)
DA725784   MX1.e 135 to 690 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DA039069 bladder MX1.e 136 to 682 2 to 548   capped   547/547
(100 %)
2 diff
(99.7 %id)
DA148633 amygdala MX1.e 136 to 703 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA587239 lung MX1.e 136 to 686 2 to 554   capped   553/553
(100 %)
2 diff
(99.7 %id)
DB020066 testis MX1.e 136 to 525 2 to 391   capped   390/390
(100 %)
0 diff
(100 %id)
DB133669 thymus MX1.e 136 to 691 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DB136754 thymus MX1.e 136 to 677 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DB160688 thymus MX1.e 137 to 730 2 to 595   capped   594/594
(100 %)
0 diff
(100 %id)
BP288347 lung MX1.e 139 to 718 1 to 580       580/582
(99 %)
8 diff
(98.7 %id)
DA945261 Spleen MX1.e 140 to 695 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
DA308237 hippocampus MX1.e 141 to 724 2 to 586   capped   585/585
(100 %)
3 diff
(99.5 %id)
BI910353 leukocyte MX1.e 147 to 885 1 to 739       739/740
(99 %)
5 diff
(99.4 %id)
TI_57235905   MX1.e 147 to 885 34 to 772       739/773
(95 %)
3 diff
(99.7 %id)
BU521726 leiomyosarcoma, uterus MX1.e 150 to 966 1 to 833       833/837
(99 %)
27 diff
(96.8 %id)
DA961912 Spleen MX1.e 164 to 718 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
AV687113 hepatocellular carcinoma MX1.e 165 to 540 1 to 377       377/387
(97 %)
2 diff
(99.5 %id)
BI461755 testis MX1.e 169 to 845 1 to 677       677/678
(99 %)
10 diff
(98.6 %id)
DB203965 trachea MX1.e 170 to 620 2 to 454   capped   453/453
(100 %)
5 diff
(98.9 %id)
DA561075 heart MX1.e 171 to 745 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
BP286410 lung MX1.e 171 to 751 1 to 581       581/581
(100 %)
4 diff
(99.4 %id)
DB093761 testis MX1.e 171 to 730 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
DA702194   MX1.e 172 to 638 2 to 469   capped   468/474
(98 %)
3 diff
(99.4 %id)
DB082619 testis MX1.e 172 to 730 2 to 562   capped   561/561
(100 %)
3 diff
(99.5 %id)
DA045463 bladder MX1.e 173 to 723 2 to 555   capped   554/554
(100 %)
7 diff
(98.8 %id)
DA272346 caudate nucleus MX1.e 173 to 745 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA887026   MX1.e 173 to 737 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA942064 Spleen MX1.e 173 to 774 2 to 605   capped   604/604
(100 %)
3 diff
(99.6 %id)
DB161200 thymus MX1.e 173 to 758 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
DA039877 bladder MX1.e 174 to 735 2 to 567   capped   566/566
(100 %)
6 diff
(99.0 %id)
DA855502 placenta MX1.e 174 to 710 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
TI_57216071   MX1.e 181 to 901 27 to 747       721/748
(96 %)
5 diff
(99.4 %id)
DA707131   MX1.e 182 to 756 2 to 577   capped   576/576
(100 %)
3 diff
(99.5 %id)
BI753662 brain MX1.e 186 to 901 1 to 718       718/719
(99 %)
8 diff
(98.9 %id)
DA041293 bladder MX1.e 187 to 627 2 to 440   capped   439/442
(99 %)
3 diff
(99.4 %id)
M33882   MX1.e 187 to 2971 1 to 2784 V379I tiling clone,   2784/2787
(99 %)
3 diff
(99.9 %id)
CD691803 normal nasopharynx MX1.e 195 to 462 17 to 286       270/286
(94 %)
2 diff
(99.4 %id)
CK002544 brain/CNS, Bulk tissue from Human Spinal cord MX1.e 198 to 827 1 to 629       629/629
(100 %)
6 diff
(99.1 %id)
DA674544   MX1.e 198 to 709 2 to 515   capped   514/514
(100 %)
4 diff
(99.3 %id)
BE244168 leukopheresis MX1.e 198 to 502 1 to 305       305/305
(100 %)
6 diff
(98.1 %id)
BP352492   MX1.e 199 to 778 1 to 580       580/582
(99 %)
2 diff
(99.7 %id)
DA044370 bladder MX1.e 200 to 762 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA158153 amygdala MX1.e 200 to 668 2 to 472   capped   471/471
(100 %)
3 diff
(99.4 %id)
DA370582 thalamus MX1.e 200 to 766 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA372209 thalamus MX1.e 200 to 772 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA454293 tongue, tumor tissue MX1.e 200 to 793 2 to 595   capped   594/594
(100 %)
2 diff
(99.7 %id)
BF673909 Prostate MX1.e 200 to 803 1 to 603       603/604
(99 %)
11 diff
(98.2 %id)
BG545407 lung MX1.e 200 to 666 1 to 467       467/467
(100 %)
1 diff
(99.8 %id)
DA619482   MX1.e 200 to 808 2 to 610   capped   609/609
(100 %)
1 diff
(99.9 %id)
DA644598   MX1.e 200 to 784 2 to 586   capped   585/587
(99 %)
3 diff
(99.5 %id)
AU122119 mammary gland MX1.e 200 to 982 2 to 785   capped   784/784
(100 %)
4 diff
(99.5 %id)
DA671361   MX1.e 200 to 791 2 to 593   capped   592/592
(100 %)
1 diff
(99.9 %id)
DA704747   MX1.e 200 to 644 2 to 446   capped   445/445
(100 %)
0 diff
(100 %id)
AU130834   MX1.e 200 to 967 2 to 772   capped   771/781
(98 %)
15 diff
(98.1 %id)
DA766922 tongue MX1.e 200 to 759 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DA939748 Spleen MX1.e 200 to 777 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DA955261 Spleen MX1.e 200 to 768 2 to 570   capped   569/569
(100 %)
3 diff
(99.5 %id)
DA958180 Spleen MX1.e 200 to 749 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DA998924 breast, tumor tissue MX1.e 200 to 770 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DB002799 breast, tumor tissue MX1.e 200 to 760 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DB004935 breast, tumor tissue MX1.e 200 to 736 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
DB197272 trachea MX1.e 200 to 778 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
BP287736 lung MX1.e 201 to 782 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA041882 bladder MX1.e 202 to 780 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA045318 bladder MX1.e 202 to 774 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
DA377091 thalamus MX1.e 202 to 752 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DA382812 thalamus MX1.e 202 to 816 2 to 616   capped   615/615
(100 %)
1 diff
(99.9 %id)
DA553038   MX1.e 202 to 771 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA560650 heart MX1.e 202 to 754 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA599677   MX1.e 202 to 769 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA699236   MX1.e 202 to 717 2 to 517   capped   516/516
(100 %)
0 diff
(100 %id)
DA700015   MX1.e 202 to 714 2 to 514   capped   513/513
(100 %)
0 diff
(100 %id)
DA705641   MX1.e 202 to 674 2 to 474   capped   473/473
(100 %)
0 diff
(100 %id)
DA706574   MX1.e 202 to 717 2 to 517   capped   516/516
(100 %)
0 diff
(100 %id)
DA706712   MX1.e 202 to 770 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA710608   MX1.e 202 to 751 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA710731   MX1.e 202 to 756 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA713518   MX1.e 202 to 727 2 to 527   capped   526/526
(100 %)
0 diff
(100 %id)
AU133022   MX1.e 202 to 1071 2 to 879   capped   878/881
(99 %)
12 diff
(98.7 %id)
DA917551 small intestine MX1.e 202 to 774 2 to 574   capped   573/573
(100 %)
3 diff
(99.5 %id)
DA943981 Spleen MX1.e 202 to 775 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
DA946198 Spleen MX1.e 202 to 751 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DB147506 thymus MX1.e 202 to 717 2 to 517   capped   516/516
(100 %)
0 diff
(100 %id)
DB191589 lung, tumor tissue MX1.e 202 to 728 2 to 528   capped   527/527
(100 %)
0 diff
(100 %id)
DA645287   MX1.e 207 to 795 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
DB259419 uterus MX1.e 207 to 788 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
DA710852   MX1.e 210 to 750 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
BM460766 leiomyosarcoma, uterus MX1.e 211 to 784 13 to 586       574/1135
(50 %)
18 diff
(98.5 %id)
BQ068247 brain MX1.e 215 to 1081 1 to 873       873/998
(87 %)
8 diff
(99.2 %id)
AW407969 lymph MX1.e 217 to 534 8 to 325       318/325
(97 %)
1 diff
(99.7 %id)
CT001785 T-Lymphocytes MX1.e 218 to 964 1 to 747       747/747
(100 %)
0 diff
(100 %id)
AU154441   MX1.e 2449 to 2971 519 to 1       519/563
(92 %)
8 diff
(98.6 %id)
AU147786 mammary gland MX1.e 2460 to 2975 515 to 1       515/570
(90 %)
11 diff
(98.1 %id)
AU152719   MX1.e 2486 to 2971 487 to 1       487/494
(98 %)
8 diff
(98.4 %id)
AK096355   MX1.f 1 to 3466 2 to 3467 D250G E299G V379I tiling clone, available from FLJ,   3467/3467
(100 %)
8 diff
(99.8 %id)
DA744023   MX1.f 1 to 499 2 to 500   capped   499/499
(100 %)
1 diff
(99.8 %id)
DA726666   MX1.f 77 to 638 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
NM_001144925.1   MX1.f 78 to 3468 1 to 3391 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 3391/3391
(100 %)
0 diff
(100 %id)
DA707405   MX1.f 121 to 692 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
BG752559 eye, normal pigmented retinal epithelium MX1.f 151 to 779 1 to 629   tiling clone,   629/629
(100 %)
2 diff
(99.7 %id)
BM931576 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid MX1.f 518 to 976 1 to 460   fully sequenced, AAA   460/460
(100 %)
2 diff
(99.6 %id)
BM684030 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid MX1.f 686 to 976 309 to 19   fully sequenced, AAA   291/291
(100 %)
0 diff
(100 %id)
TI_154145890   MX1.f 711 to 1324 59 to 676       618/843
(73 %)
58 diff
(93.2 %id)
AL553896 placenta, Placenta Cot 25-normalized MX1.f 716 to 1667 1 to 952       952/952
(100 %)
2 diff
(99.8 %id)
TI_57163456   MX1.f 716 to 1465 37 to 787       751/795
(94 %)
6 diff
(99.3 %id)
TI_154147138   MX1.f 716 to 1119 88 to 491       404/418
(96 %)
9 diff
(97.9 %id)
BI838011 pooled pancreas and spleen MX1.f 717 to 1465 1 to 751       751/759
(98 %)
8 diff
(99.0 %id)
CD710389 normal nasopharynx MX1.f 718 to 1115 56 to 454       399/454
(87 %)
6 diff
(98.7 %id)
AL118907 amygdala MX1.f 718 to 1210 1 to 493       493/493
(100 %)
1 diff
(99.8 %id)
BF685131 leiomyosarcoma cell line, uterus MX1.f 718 to 1439 12 to 725       714/853
(83 %)
26 diff
(97.0 %id)
BM542305 melanotic melanoma, skin MX1.f 725 to 1380 1 to 659       659/886
(74 %)
30 diff
(96.7 %id)
BC032602 Uterus, leiomyosarcoma MX1.f 745 to 3468 12 to 2735 V379I tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 2724/2724
(100 %)
3 diff
(99.9 %id)
BM464205 leiomyosarcoma, uterus MX1.f 745 to 1716 1 to 979       979/1081
(90 %)
20 diff
(98.2 %id)
CR977458 T-Lymphocytes MX1.f 745 to 1608 1 to 866       866/866
(100 %)
4 diff
(99.6 %id)
DB148802 thymus MX1.f 749 to 1320 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
A00209   MX1.f 758 to 1398 1 to 641       641/641
(100 %)
0 diff
(100 %id)
BG339290 leiomyosarcoma cell line, uterus MX1.f 763 to 1421 1 to 649       649/897
(72 %)
23 diff
(97.5 %id)
FN099145 breast carcinoma MX1.f 776 to 854 78 to 1     Submitted on the opposite strand 78/79
(98 %)
1 diff
(98.8 %id)
DA388239 thalamus MX1.f 793 to 1382 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
DB185500 liver, tumor tissue MX1.f 802 to 1350 14 to 562   capped   549/561
(97 %)
0 diff
(100 %id)
CR592170 B cells (Ramos cell line) Cot 25-normalized MX1.f 815 to 3410 1 to 2596 exact tiling clone,   2596/2596
(100 %)
0 diff
(100 %id)
AL583307 B cells from Burkitt lymphoma MX1.f 815 to 1755 1 to 935       935/1018
(91 %)
16 diff
(98.5 %id)
BX476105   MX1.f 815 to 1029 33 to 247       215/247
(87 %)
2 diff
(99.2 %id)
M30817   MX1.f 816 to 3466 1 to 2651 L164R V379I     2651/2651
(100 %)
12 diff
(99.6 %id)
AW384279 head_neck MX1.f 819 to 1364 550 to 4       547/550
(99 %)
2 diff
(99.7 %id)
AW029047 poorly differentiated adenocarcinoma withsignet ring cell features, stomach MX1.f 859 to 1325 1 to 469     Submitted on the opposite strand 469/512
(91 %)
20 diff
(96.1 %id)
DA043799 bladder MX1.f 898 to 1462 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
BQ334897 marrow MX1.f 904 to 1129 249 to 21       229/252
(90 %)
4 diff
(98.5 %id)
BF129208 B-cells, primary B-cells from tonsils (cell line) MX1.f 933 to 1616 1 to 688       688/1102
(62 %)
23 diff
(98.0 %id)
BQ708369 Spleen MX1.f 960 to 1764 1 to 811       811/900
(90 %)
22 diff
(97.6 %id)
DB274221 uterus MX1.f 965 to 1528 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
BE886694.
matches multiple genes
leiomyosarcoma, uterus, Uterus, leiomyosarcoma MX1.f 978 to 1730 1 to 747   available from MGC, Possibly primed on the genome, locally A rich (21/21 A in genome downstream of last aligned base), also hits gene florkleeby 747/748
(99 %)
20 diff
(97.4 %id)
BE934768 head_neck MX1.f 981 to 1118 139 to 3       137/139
(98 %)
0 diff
(100 %id)
AL703067 human skeletal muscle MX1.f 983 to 1136 1 to 154       154/154
(100 %)
1 diff
(99.4 %id)
AW339767 carcinoid, lung MX1.f 994 to 1424 1 to 441     Submitted on the opposite strand 441/502
(87 %)
15 diff
(97.1 %id)
BG055292 carcinoid, lung MX1.f 996 to 1619 1 to 624     Submitted on the opposite strand 624/665
(93 %)
13 diff
(98.1 %id)
DA701239   MX1.f 1010 to 1538 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
TI_1948140381   MX1.f 1018 to 1664 119 to 768       650/1320
(49 %)
14 diff
(99.0 %id)
TI_1948140714   MX1.f 1018 to 1875 117 to 986       870/1322
(65 %)
56 diff
(95.8 %id)
TI_1948140715   MX1.f 1018 to 1911 122 to 1021       900/1292
(69 %)
32 diff
(97.6 %id)
TI_1948141043   MX1.f 1018 to 1753 117 to 859       743/1342
(55 %)
21 diff
(98.5 %id)
TI_1948141044   MX1.f 1018 to 1813 127 to 930       802/1372
(58 %)
18 diff
(98.7 %id)
TI_1948141380   MX1.f 1018 to 1876 120 to 978       859/1278
(67 %)
29 diff
(97.8 %id)
TI_1948141381   MX1.f 1018 to 1917 125 to 1033       909/1303
(69 %)
37 diff
(97.2 %id)
TI_1948140382   MX1.f 1019 to 1880 124 to 994       871/1257
(69 %)
28 diff
(97.8 %id)
CV030782 mixed MX1.f 1025 to 1631 1 to 607       607/607
(100 %)
1 diff
(99.9 %id)
BM470652 leiomyosarcoma, uterus MX1.f 1027 to 1925 1 to 901       901/1002
(89 %)
26 diff
(97.5 %id)
GW493613 stomach MX1.f 1087 to 1435 372 to 33   AAA Submitted on the opposite strand 340/351
(96 %)
6 diff
(98.3 %id)
DB003671 breast, tumor tissue MX1.f 1091 to 1657 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB129051 thymus MX1.f 1158 to 1717 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
BM561666 blood, natural killer cells, cell line MX1.f 1160 to 2147 11 to 1003       993/1008
(98 %)
25 diff
(97.6 %id)
BQ053898 blood, natural killer cells, cell line MX1.f 1222 to 2147 1 to 933       933/1075
(86 %)
32 diff
(97.1 %id)
BF379088 uterus_tumor MX1.f 1270 to 1612 1 to 345       345/345
(100 %)
5 diff
(98.6 %id)
BF974392 B-cells, primary B-cells from tonsils (cell line) MX1.f 1274 to 2033 1 to 760       760/981
(77 %)
14 diff
(98.6 %id)
BC014222 Primary B-Cells from Tonsils MX1.f 1275 to 3466 1 to 2192   available from MGC, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 2192/2192
(100 %)
5 diff
(99.8 %id)
R88402   MX1.f 1301 to 1429 1 to 129       129/129
(100 %)
0 diff
(100 %id)
CD688396 normal nasopharynx MX1.f 1336 to 1934 11 to 609       599/609
(98 %)
1 diff
(99.9 %id)
BQ052690 blood, natural killer cells, cell line MX1.f 1343 to 2298 1 to 973       973/1039
(93 %)
34 diff
(96.8 %id)
DB103615 thymus MX1.f 1379 to 1946 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
AW403738 lymph MX1.f 1394 to 1578 1 to 183     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 183/183
(100 %)
9 diff
(95.1 %id)
DA707071   MX1.f 1418 to 1992 2 to 577   capped   576/576
(100 %)
3 diff
(99.5 %id)
BP332070 renal proximal tubule MX1.f 1425 to 2005 1 to 584       582/584
(99 %)
7 diff
(98.9 %id)
DA342657 substantia nigra MX1.f 1434 to 1992 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
AU121806 mammary gland MX1.f 1449 to 2294 2 to 846   capped   845/847
(99 %)
15 diff
(98.3 %id)
CB127818 cervix, Uterine MX1.f 1451 to 2032 1 to 582       582/591
(98 %)
0 diff
(100 %id)
BU145822 dorsal root ganglia MX1.f 1462 to 2296 1 to 837       837/944
(88 %)
12 diff
(98.8 %id)
BX349360   MX1.f 1469 to 2294 1 to 832       832/837
(99 %)
23 diff
(97.3 %id)
AW802239 uterus MX1.f 1493 to 1798 307 to 1       307/307
(100 %)
2 diff
(99.4 %id)
AA294897 Pancreas MX1.f 1494 to 1728 3 to 237       235/237
(99 %)
1 diff
(99.6 %id)
BG744074 blood, natural killer cells, cell line MX1.f 1576 to 2321 1 to 749       749/754
(99 %)
7 diff
(99.1 %id)
AA148159 colon, tumor MX1.f 1586 to 2153 1 to 570       570/570
(100 %)
6 diff
(99.0 %id)
BU150025 ductal carcinoma, cell line, Pancreas MX1.f 1590 to 2457 1 to 879       879/927
(94 %)
19 diff
(98.0 %id)
BQ878737 ductal carcinoma, cell line, Pancreas MX1.f 1590 to 2161 1 to 576       576/1022
(56 %)
10 diff
(99.1 %id)
BQ688620 ductal carcinoma, cell line, Pancreas MX1.f 1590 to 2512 1 to 932       930/936
(99 %)
14 diff
(98.6 %id)
AU135618 placenta MX1.f 1590 to 2298 2 to 715   capped   714/793
(90 %)
6 diff
(99.3 %id)
CD700744 normal nasopharynx MX1.f 1600 to 2229 23 to 652       630/652
(96 %)
0 diff
(100 %id)
BP294398 Liver MX1.f 1614 to 2195 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA873307 Prostate MX1.f 1616 to 2175 2 to 561   capped   560/562
(99 %)
3 diff
(99.5 %id)
EB387119 eye, optic nerve MX1.f 1627 to 2289 1 to 663       663/663
(100 %)
0 diff
(100 %id)
AW376350 colon MX1.f 1654 to 2030 403 to 22       382/405
(94 %)
6 diff
(98.6 %id)
BQ307752 breast MX1.f 1676 to 2269 600 to 8       593/600
(98 %)
8 diff
(98.7 %id)
BQ672015 epidermoid carcinoma, cell line, salivary gland MX1.f 1681 to 2574 1 to 900       900/905
(99 %)
11 diff
(98.8 %id)
EB388095 eye, optic nerve MX1.f 1685 to 2502 1 to 818       818/818
(100 %)
1 diff
(99.9 %id)
AW384094 head_neck MX1.f 1688 to 2275 11 to 597       587/598
(98 %)
10 diff
(98.4 %id)
AW384107 head_neck MX1.f 1691 to 2297 18 to 624       607/638
(95 %)
4 diff
(99.4 %id)
AW384086 head_neck MX1.f 1693 to 2298 12 to 615       604/628
(96 %)
21 diff
(96.7 %id)
AW384089 head_neck MX1.f 1699 to 2316 619 to 3       617/619
(99 %)
6 diff
(99.1 %id)
AW384111 head_neck MX1.f 1699 to 2298 601 to 4       596/601
(99 %)
3 diff
(99.6 %id)
BE699641 nervous_normal MX1.f 1701 to 2064 12 to 375       364/375
(97 %)
3 diff
(99.2 %id)
BQ427797 leiomyosarcoma, uterus MX1.f 1719 to 2560 1 to 842       842/842
(100 %)
2 diff
(99.8 %id)
AA361869   MX1.f 1741 to 1929 1 to 189       189/189
(100 %)
0 diff
(100 %id)
DB000675 breast, tumor tissue MX1.f 1762 to 2298 2 to 539   capped   538/538
(100 %)
1 diff
(99.9 %id)
BM541627 leiomyosarcoma, uterus MX1.f 1799 to 2846 1 to 1061       1061/1063
(99 %)
30 diff
(97.2 %id)
CB151538 cervix, Uterine MX1.f 1852 to 2456 1 to 605       605/610
(99 %)
3 diff
(99.6 %id)
BX372448   MX1.f 1860 to 2782 918 to 1       918/918
(100 %)
36 diff
(96.1 %id)
AA487958 lung MX1.f 1882 to 2352 1 to 471       471/471
(100 %)
2 diff
(99.6 %id)
AI580165 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MX1.f 1895 to 2561 665 to 1       665/671
(99 %)
15 diff
(97.8 %id)
AA149698 colon, tumor MX1.f 1901 to 2373 1 to 481       481/513
(93 %)
15 diff
(97.1 %id)
BQ933342 epidermoid carcinoma, cell line, lung MX1.f 1905 to 2839 1 to 935       935/935
(100 %)
14 diff
(98.6 %id)
BP253304 Kidney MX1.f 1981 to 2563 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BQ879039 ductal carcinoma, cell line, Pancreas MX1.f 2026 to 2856 1 to 839       839/847
(99 %)
8 diff
(99.1 %id)
BF174556 blood MX1.f 2051 to 2268 1 to 218       218/218
(100 %)
1 diff
(99.6 %id)
BP302232   MX1.f 2051 to 2628 1 to 580       580/580
(100 %)
12 diff
(98.0 %id)
CB151492 cervix, Uterine MX1.f 2058 to 2725 1 to 665       665/665
(100 %)
4 diff
(99.4 %id)
CB151270 cervix, Uterine MX1.f 2062 to 2621 1 to 559       559/559
(100 %)
3 diff
(99.5 %id)
BP330619 rectum MX1.f 2063 to 2642 1 to 579       579/582
(99 %)
2 diff
(99.7 %id)
BU520815 leiomyosarcoma, uterus MX1.f 2088 to 2927 1 to 840       840/841
(99 %)
8 diff
(99.1 %id)
CB127654 cervix, Uterine MX1.f 2128 to 2622 1 to 495       495/495
(100 %)
0 diff
(100 %id)
BF683137 leiomyosarcoma cell line, uterus MX1.f 2135 to 2814 1 to 692       660/1103
(59 %)
43 diff
(96.2 %id)
BF972585 leiomyosarcoma cell line, uterus MX1.f 2136 to 2908 1 to 779       777/976
(79 %)
27 diff
(97.3 %id)
BU597383 mixed (pool of 40 RNAs) MX1.f 2143 to 2953 13 to 829       817/831
(98 %)
17 diff
(98.0 %id)
CB152462 cervix, Uterine MX1.f 2151 to 2839 1 to 689       689/689
(100 %)
1 diff
(99.9 %id)
TI_1948141383   MX1.f 2151 to 3016 997 to 129       869/1283
(67 %)
15 diff
(98.9 %id)
BM829288 Ascites, stomach MX1.f 2153 to 2681 1 to 529       529/529
(100 %)
5 diff
(99.1 %id)
TI_1948141046   MX1.f 2156 to 3016 1000 to 137       864/1272
(67 %)
15 diff
(98.9 %id)
TI_1948141382   MX1.f 2156 to 3016 988 to 118       871/1359
(64 %)
30 diff
(97.8 %id)
TI_1948140384   MX1.f 2157 to 3016 999 to 136       864/1297
(66 %)
28 diff
(97.9 %id)
TI_1948140717   MX1.f 2188 to 3016 971 to 132       838/1313
(63 %)
19 diff
(98.6 %id)
AA304560 aorta MX1.f 2193 to 2504 1 to 316       316/320
(98 %)
8 diff
(97.5 %id)
CV375985 nervous_tumor MX1.f 2196 to 2402 1 to 210       210/211
(99 %)
23 diff
(89.1 %id)
TI_1948141045   MX1.f 2198 to 3016 948 to 121       828/1363
(60 %)
24 diff
(98.3 %id)
BQ320042 colon MX1.f 2200 to 2650 9 to 460       452/483
(93 %)
14 diff
(97.2 %id)
AW794580 uterus MX1.f 2202 to 2513 315 to 4       312/315
(99 %)
3 diff
(99.1 %id)
AW748384 breast MX1.f 2205 to 2529 328 to 1       328/328
(100 %)
7 diff
(97.9 %id)
AW880777 ovary MX1.f 2205 to 2449 264 to 23       242/264
(91 %)
0 diff
(100 %id)
BP338910 Spleen MX1.f 2219 to 2798 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
CD696414 normal nasopharynx MX1.f 2224 to 2642 25 to 444       420/444
(94 %)
1 diff
(99.8 %id)
BQ306818 breast MX1.f 2253 to 2836 1 to 589       589/613
(96 %)
43 diff
(93.0 %id)
TI_1948140716   MX1.f 2294 to 3016 845 to 119       727/1458
(49 %)
20 diff
(98.7 %id)
TI_1948140383   MX1.f 2296 to 3016 846 to 123       724/1378
(52 %)
5 diff
(99.7 %id)
CD614864   MX1.f 2316 to 3048 8 to 744       737/748
(98 %)
6 diff
(99.2 %id)
CD614860   MX1.f 2332 to 3048 8 to 726       719/740
(97 %)
5 diff
(99.4 %id)
AA306065 aorta MX1.f 2336 to 2675 1 to 341       341/341
(100 %)
1 diff
(99.8 %id)
CD614862   MX1.f 2346 to 3048 715 to 14       702/742
(94 %)
2 diff
(99.8 %id)
CD614863   MX1.f 2346 to 2914 8 to 576       569/576
(98 %)
1 diff
(99.9 %id)
AA477235 ovarian tumor, ovary MX1.f 2346 to 2803 1 to 458       458/458
(100 %)
1 diff
(99.8 %id)
BX096449 ovarian tumor, ovary MX1.f 2347 to 3024 1 to 678       678/678
(100 %)
1 diff
(99.9 %id)
CB120263 Liver MX1.f 2357 to 2804 1 to 448       448/448
(100 %)
0 diff
(100 %id)
FN153136 breast carcinoma MX1.f 2358 to 2424 1 to 66       66/78
(84 %)
4 diff
(94.9 %id)
AA112842 muscle, skeletal muscle MX1.f 2372 to 2846 1 to 476       476/477
(99 %)
2 diff
(99.6 %id)
BF908893 uterus_tumor MX1.f 2378 to 2594 221 to 5     Submitted on the opposite strand 217/234
(92 %)
0 diff
(100 %id)
CD614865   MX1.f 2386 to 3048 672 to 10       663/672
(98 %)
0 diff
(100 %id)
R35815 whole brain MX1.f 2392 to 2741 1 to 358       358/363
(98 %)
20 diff
(94.5 %id)
AA233694 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MX1.f 2397 to 2827 1 to 430       430/430
(100 %)
5 diff
(98.9 %id)
BF974977 B-cells, primary B-cells from tonsils (cell line) MX1.f 2419 to 3200 1 to 781       781/977
(79 %)
15 diff
(98.5 %id)
BG341829 B-cells, primary B-cells from tonsils (cell line) MX1.f 2419 to 3124 1 to 713       713/1083
(65 %)
23 diff
(97.9 %id)
CD614861   MX1.f 2421 to 3048 637 to 10       628/637
(98 %)
1 diff
(99.9 %id)
BM461790 leiomyosarcoma, uterus MX1.f 2426 to 3272 1 to 855       855/893
(95 %)
33 diff
(96.4 %id)
AA366868 Pancreas MX1.f 2431 to 2758 1 to 329       329/333
(98 %)
5 diff
(98.5 %id)
AA295337 Pancreas MX1.f 2444 to 2776 1 to 337       337/337
(100 %)
6 diff
(98.3 %id)
AA295418 Pancreas MX1.f 2444 to 2738 1 to 295       295/295
(100 %)
2 diff
(99.4 %id)
BM705282 eye, RPE and Choroid MX1.f 2454 to 2865 1 to 412     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 412/412
(100 %)
2 diff
(99.6 %id)
AL583260 B cells from Burkitt lymphoma MX1.f 2456 to 3410 950 to 1       950/999
(95 %)
16 diff
(98.4 %id)
BM686951 eye, optic nerve MX1.f 2456 to 2978 11 to 533     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 523/533
(98 %)
3 diff
(99.5 %id)
TI_151750264   MX1.f 2456 to 3468 1107 to 74   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 884/1116
(79 %)
61 diff
(94.6 %id)
AL576770 placenta, Placenta Cot 25-normalized MX1.f 2457 to 3453 995 to 1       995/995
(100 %)
11 diff
(98.9 %id)
AW802186 uterus MX1.f 2458 to 2823 366 to 1       366/374
(97 %)
5 diff
(98.7 %id)
AW360883 colon MX1.f 2459 to 2851 1 to 393       393/395
(99 %)
10 diff
(97.5 %id)
AY186254   MX1.f 2480 to 2728 1 to 249       249/250
(99 %)
2 diff
(99.2 %id)
H61837 ovarian tumor, ovary MX1.f 2505 to 2878 1 to 375       375/376
(99 %)
7 diff
(98.2 %id)
CB161834 Liver MX1.f 2505 to 3055 1 to 551       551/551
(100 %)
3 diff
(99.5 %id)
AA053202 colon, tumor MX1.f 2509 to 2925 1 to 421       421/426
(98 %)
6 diff
(98.6 %id)
TI_227713164   MX1.f 2532 to 3466 1007 to 79   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 929/1028
(90 %)
15 diff
(98.6 %id)
AA419530.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MX1.f 2535 to 3133 1 to 597     also hits gene POLR2H 597/597
(100 %)
12 diff
(98.0 %id)
BX437157 thymus MX1.f 2541 to 3437 903 to 1       903/907
(99 %)
10 diff
(98.9 %id)
FN127357 breast carcinoma MX1.f 2542 to 2636 1 to 96       96/97
(98 %)
6 diff
(93.9 %id)
W30997 senescent fibroblast MX1.f 2550 to 2921 1 to 380       380/380
(100 %)
10 diff
(97.4 %id)
AA193638.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MX1.f 2555 to 2962 1 to 410     also hits gene steygu 410/410
(100 %)
14 diff
(96.6 %id)
AA232871 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MX1.f 2555 to 2979 1 to 425   fully sequenced,   425/425
(100 %)
6 diff
(98.6 %id)
R00415 liver and spleen MX1.f 2559 to 2908 1 to 364       364/381
(95 %)
20 diff
(94.8 %id)
N31876 melanocyte MX1.f 2573 to 3079 1 to 517   fully sequenced,   517/517
(100 %)
53 diff
(89.8 %id)
AA456886 germinal center B cell MX1.f 2574 to 2920 1 to 349   fully sequenced,   349/349
(100 %)
3 diff
(99.2 %id)
TI_149305462   MX1.f 2580 to 3464 967 to 88   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 880/970
(90 %)
13 diff
(98.7 %id)
BG744742 blood, natural killer cells, cell line MX1.f 2594 to 3418 825 to 1       825/825
(100 %)
7 diff
(99.2 %id)
BE710654 head_neck MX1.f 2630 to 3003 1 to 371       371/371
(100 %)
6 diff
(98.4 %id)
AI419322 brain, glioblastoma (pooled) MX1.f 2636 to 3466 825 to 1       826/832
(99 %)
22 diff
(97.4 %id)
TI_159694557   MX1.f 2636 to 3466 917 to 95   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 823/1006
(81 %)
16 diff
(98.5 %id)
CR997589 T-Lymphocytes MX1.f 2650 to 3465 1 to 816       816/848
(96 %)
4 diff
(99.6 %id)
BG997152 head_neck MX1.f 2655 to 3027 31 to 403       373/405
(92 %)
5 diff
(98.8 %id)
AA004402 liver and spleen MX1.f 2661 to 3022 16 to 385       370/385
(96 %)
10 diff
(97.5 %id)
N48037 melanocyte MX1.f 2662 to 3009 1 to 352       352/352
(100 %)
8 diff
(97.8 %id)
AI375649 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MX1.f 2667 to 3467 799 to 6       794/803
(98 %)
10 diff
(98.8 %id)
BM704470 eye, Retina Foveal and Macular MX1.f 2667 to 3039 1 to 373   fully sequenced, Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 373/373
(100 %)
0 diff
(100 %id)
BM687447 eye, eye anterior segment MX1.f 2671 to 3219 9 to 557       549/557
(98 %)
5 diff
(99.2 %id)
TI_149297989   MX1.f 2680 to 3466 858 to 81   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 778/930
(83 %)
18 diff
(98.1 %id)
CD367498 Alveolar Macrophage, lung MX1.f 2682 to 3466 800 to 17   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 784/784
(100 %)
3 diff
(99.7 %id)
BQ345674 nervous_tumor MX1.f 2690 to 2833 151 to 7       145/151
(96 %)
2 diff
(98.7 %id)
AA307162 aorta MX1.f 2691 to 2924 1 to 235       235/235
(100 %)
2 diff
(99.2 %id)
AW505188 lymph MX1.f 2695 to 2963 1 to 269       269/269
(100 %)
4 diff
(98.6 %id)
R74116 placenta MX1.f 2697 to 2885 1 to 189       189/189
(100 %)
1 diff
(99.5 %id)
TI_154161742   MX1.f 2700 to 3236 76 to 612       537/563
(95 %)
12 diff
(97.9 %id)
AA304120 aorta MX1.f 2727 to 3018 1 to 296       296/296
(100 %)
8 diff
(97.3 %id)
CD370433 Alveolar Macrophage, lung MX1.f 2741 to 3466 742 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 724/724
(100 %)
2 diff
(99.8 %id)
BU685811 lung, Primary Lung Epithelial Cells MX1.f 2757 to 3464 726 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 708/708
(100 %)
3 diff
(99.6 %id)
CA307542 Alveolar Macrophage, lung MX1.f 2757 to 3466 726 to 17   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 710/710
(100 %)
1 diff
(99.9 %id)
BQ576219 Chondrosarcoma Grade II, Left Pelvis MX1.f 2759 to 3468 728 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 710/710
(100 %)
0 diff
(100 %id)
AI923670 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) MX1.f 2760 to 3467 710 to 3       708/710
(99 %)
3 diff
(99.6 %id)
AI358951 brain, glioblastoma (pooled) MX1.f 2773 to 3467 701 to 1       701/722
(97 %)
16 diff
(97.8 %id)
BU616248 Bone, Subchondral Bone MX1.f 2774 to 3464 709 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 691/691
(100 %)
0 diff
(100 %id)
BQ447055 Knee, Osteoarthritic Cartilage MX1.f 2775 to 3466 708 to 17   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 692/692
(100 %)
0 diff
(100 %id)
BQ447080 Knee, Osteoarthritic Cartilage MX1.f 2775 to 3466 708 to 17   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 692/692
(100 %)
0 diff
(100 %id)
CA306706 Alveolar Macrophage, lung MX1.f 2775 to 3468 710 to 17   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 694/694
(100 %)
0 diff
(100 %id)
AA740857 germinal center B cell MX1.f 2779 to 3466 714 to 30   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 685/880
(77 %)
4 diff
(99.6 %id)
AI018493 breast MX1.f 2779 to 3468 691 to 1       691/694
(99 %)
6 diff
(99.2 %id)
BM982970 lung, Primary Lung Cystic Fibrosis EpithelialCells MX1.f 2779 to 3466 703 to 17   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 687/691
(99 %)
4 diff
(99.5 %id)
BQ774424 Chondrosarcoma Grade II, Left Pelvis MX1.f 2779 to 3466 703 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 685/689
(99 %)
3 diff
(99.6 %id)
CA309235 Alveolar Macrophage, lung MX1.f 2779 to 3464 699 to 16   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 684/689
(99 %)
3 diff
(99.6 %id)
BG187094   MX1.f 2780 to 2987 1 to 208       208/208
(100 %)
4 diff
(98.1 %id)
BG189787   MX1.f 2780 to 3263 1 to 483       483/779
(62 %)
26 diff
(96.7 %id)
BG189864   MX1.f 2780 to 3467 1 to 688       688/691
(99 %)
6 diff
(99.2 %id)
AI949126 poorly differentiated adenocarcinoma withsignet ring cell features, stomach MX1.f 2780 to 3467 694 to 8       687/716
(95 %)
0 diff
(100 %id)
AI686544 serous papillary carcinoma, high grade, 2pooled tumors, uterus MX1.f 2783 to 3465 689 to 9       681/689
(98 %)
0 diff
(100 %id)
TI_154132193   MX1.f 2783 to 3464 784 to 102   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 683/759
(89 %)
8 diff
(99.0 %id)
AI689293 serous papillary carcinoma, high grade, 2pooled tumors, uterus MX1.f 2787 to 3464 680 to 1       680/680
(100 %)
27 diff
(96.1 %id)
BG202036   MX1.f 2793 to 3103 10 to 319       310/319
(97 %)
0 diff
(100 %id)
AW408537 lymph MX1.f 2795 to 3208 1 to 414       414/414
(100 %)
6 diff
(98.6 %id)
AA143789 colon, tumor MX1.f 2801 to 3437 628 to 1       628/633
(99 %)
22 diff
(96.6 %id)
TI_154148397   MX1.f 2802 to 3359 89 to 646       558/558
(100 %)
13 diff
(97.7 %id)
CR595895 Placenta Cot 25-normalized MX1.f 2803 to 3462 1 to 660       660/660
(100 %)
0 diff
(100 %id)
BX392518 Placenta Cot 25-normalized MX1.f 2803 to 3459 662 to 5       658/662
(99 %)
0 diff
(100 %id)
BX396452 Placenta Cot 25-normalized MX1.f 2803 to 3301 1 to 501       501/660
(75 %)
11 diff
(98.4 %id)
BF057399 fibrotheoma, ovary MX1.f 2807 to 3467 662 to 7       656/662
(99 %)
0 diff
(100 %id)
BX482492   MX1.f 2810 to 3466 675 to 19   AAA Submitted on the opposite strand 657/657
(100 %)
0 diff
(100 %id)
FN116171 breast carcinoma MX1.f 2814 to 2885 73 to 1     Submitted on the opposite strand 73/74
(98 %)
1 diff
(98.7 %id)
AA128097 uterus MX1.f 2825 to 3033 15 to 220       206/224
(91 %)
7 diff
(96.9 %id)
AA890179 pooled MX1.f 2828 to 3466 636 to 1       636/636
(100 %)
5 diff
(99.3 %id)
AW954203   MX1.f 2836 to 3465 633 to 1     Submitted on the opposite strand 633/640
(98 %)
36 diff
(94.4 %id)
AI991650 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) MX1.f 2846 to 3406 562 to 1       562/562
(100 %)
21 diff
(96.3 %id)
BU940999 mixed (pool of 40 RNAs) MX1.f 2847 to 3306 1 to 460       460/488
(94 %)
7 diff
(98.6 %id)
AW378570 head_neck MX1.f 2850 to 3469 625 to 10       616/631
(97 %)
0 diff
(100 %id)
BQ447698 Knee, Osteoarthritic Cartilage MX1.f 2853 to 3464 630 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 612/612
(100 %)
1 diff
(99.9 %id)
AW276428 lung, two pooled squamous cell carcinomas MX1.f 2854 to 3467 613 to 1       613/613
(100 %)
3 diff
(99.6 %id)
AA630151 lung MX1.f 2860 to 3404 537 to 1       537/537
(100 %)
15 diff
(97.3 %id)
BI013404 lung_tumor MX1.f 2861 to 3415 552 to 1       552/584
(94 %)
7 diff
(98.9 %id)
BF740135 brain, glioblastoma (pooled) MX1.f 2870 to 3466 605 to 1       605/608
(99 %)
9 diff
(98.6 %id)
BF739150 bladder_tumor MX1.f 2880 to 3308 1 to 433       433/440
(98 %)
23 diff
(94.8 %id)
AI218887 pooled MX1.f 2882 to 3460 583 to 1       583/587
(99 %)
83 diff
(85.9 %id)
BF593620 brain, glioblastoma (pooled) MX1.f 2886 to 3467 582 to 1       582/583
(99 %)
0 diff
(100 %id)
AA457042 germinal center B cell MX1.f 2890 to 3472 580 to 1   fully sequenced,   580/580
(100 %)
9 diff
(98.5 %id)
AA826781 epithelium (cell line), Prostate MX1.f 2894 to 3466 583 to 11   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 573/573
(100 %)
13 diff
(97.8 %id)
AI610786 serous papillary carcinoma, high grade, 2pooled tumors, uterus MX1.f 2894 to 3468 573 to 1       573/573
(100 %)
3 diff
(99.5 %id)
AW273393 serous papillary carcinoma, high grade, 2pooled tumors, uterus MX1.f 2895 to 3467 571 to 1       571/571
(100 %)
4 diff
(99.3 %id)
AW305311 brain, three pooled meningiomas MX1.f 2902 to 3467 571 to 5       567/571
(99 %)
0 diff
(100 %id)
AW574807 lymph MX1.f 2906 to 3464 576 to 18   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 559/559
(100 %)
0 diff
(100 %id)
AA303818 aorta MX1.f 2907 to 3194 1 to 287       287/292
(98 %)
4 diff
(98.7 %id)
W63575 senescent fibroblast MX1.f 2907 to 3438 24 to 555       532/555
(95 %)
0 diff
(100 %id)
AU147554 mammary gland MX1.f 2910 to 3468 555 to 1       555/556
(99 %)
19 diff
(96.6 %id)
AI243289 pooled MX1.f 2911 to 3467 556 to 2       555/556
(99 %)
0 diff
(100 %id)
BM695585 eye, optic nerve MX1.f 2911 to 3464 1 to 554   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 554/554
(100 %)
3 diff
(99.5 %id)
AA410900.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MX1.f 2912 to 3424 550 to 44     also hits gene TRPM1 507/561
(90 %)
0 diff
(100 %id)
AA974953 Kidney MX1.f 2912 to 3468 550 to 2       549/553
(99 %)
0 diff
(100 %id)
AI421949 brain, glioblastoma (pooled) MX1.f 2912 to 3466 554 to 1       554/560
(98 %)
1 diff
(99.9 %id)
BQ017516 lung, Lung Focal Fibrosis MX1.f 2928 to 3466 555 to 17   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 539/539
(100 %)
0 diff
(100 %id)
AI187750   MX1.f 2940 to 3467 527 to 3       525/531
(98 %)
0 diff
(100 %id)
BP387195 pancreatic islet MX1.f 2945 to 3467 1 to 523     Submitted on the opposite strand 523/526
(99 %)
1 diff
(99.9 %id)
FN046140 breast carcinoma MX1.f 2947 to 3049 103 to 1     Submitted on the opposite strand 103/103
(100 %)
2 diff
(98.1 %id)
AA835410 Spleen MX1.f 2951 to 3465 510 to 4       507/510
(99 %)
0 diff
(100 %id)
BP388981 pancreatic islet MX1.f 2952 to 3451 1 to 499     Submitted on the opposite strand 499/500
(99 %)
2 diff
(99.6 %id)
AA262949 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MX1.f 2954 to 3466 509 to 1   fully sequenced,   509/509
(100 %)
6 diff
(98.9 %id)
AA127870 uterus MX1.f 2955 to 3467 1 to 527       527/527
(100 %)
22 diff
(95.9 %id)
DB324891   MX1.f 2958 to 3466 509 to 1       509/510
(99 %)
0 diff
(100 %id)
AA858199 epithelium (cell line), Prostate MX1.f 2960 to 3421 460 to 1       460/460
(100 %)
6 diff
(98.7 %id)
AW241907 pooled MX1.f 2961 to 3467 510 to 2       509/510
(99 %)
0 diff
(100 %id)
AI093096 heart MX1.f 2966 to 3465 502 to 3       500/502
(99 %)
0 diff
(100 %id)
AA135020 colon, tumor MX1.f 2972 to 3373 1 to 412       412/412
(100 %)
13 diff
(96.9 %id)
AI094995 brain, glioblastoma (pooled) MX1.f 2976 to 3467 493 to 2       492/493
(99 %)
0 diff
(100 %id)
AW749051 breast MX1.f 2977 to 3390 492 to 75       418/492
(84 %)
0 diff
(100 %id)
AI031872 brain, glioblastoma (pooled) MX1.f 2977 to 3465 522 to 36       487/563
(86 %)
0 diff
(100 %id)
BP386964 pancreatic islet MX1.f 2978 to 3465 1 to 488     Submitted on the opposite strand 488/491
(99 %)
1 diff
(99.8 %id)
AA514209 colon MX1.f 2978 to 3465 480 to 1       480/484
(99 %)
29 diff
(94.1 %id)
AI393690 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MX1.f 2978 to 3468 483 to 1       483/483
(100 %)
10 diff
(98.0 %id)
AA928572 pooled germ cell tumors MX1.f 2980 to 3467 486 to 1       486/763
(63 %)
6 diff
(99.3 %id)
AA593863 colon, colon tumor MX1.f 2981 to 3468 487 to 1       487/487
(100 %)
2 diff
(99.6 %id)
AA975468 carcinoid, lung MX1.f 2981 to 3462 478 to 1       478/481
(99 %)
6 diff
(98.8 %id)
TI_151739890   MX1.f 2983 to 3464 598 to 117   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 482/483
(99 %)
3 diff
(99.4 %id)
AI346888 adenocarcinoma, colon MX1.f 2985 to 3466 479 to 1       479/479
(100 %)
4 diff
(99.2 %id)
AI192762 lung MX1.f 2989 to 3467 477 to 1       477/477
(100 %)
5 diff
(99.0 %id)
BM669018 eye, RPE and Choroid MX1.f 2990 to 3468 497 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 479/479
(100 %)
0 diff
(100 %id)
AI167537 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MX1.f 2992 to 3461 470 to 1       470/502
(93 %)
28 diff
(94.5 %id)
AI275426 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MX1.f 2994 to 3466 491 to 18   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 474/478
(99 %)
24 diff
(95.0 %id)
AW090334 brain, tumor, 5 pooled (see description) MX1.f 2995 to 3464 468 to 1       468/468
(100 %)
5 diff
(99.0 %id)
BM992966 lung, Metastatic Chondrosarcoma MX1.f 2996 to 3467 487 to 16       472/487
(96 %)
0 diff
(100 %id)
AA291508 ovarian tumor, ovary MX1.f 3001 to 3468 467 to 1       467/467
(100 %)
3 diff
(99.4 %id)
BP393412 pancreatic islet MX1.f 3003 to 3459 1 to 457     Submitted on the opposite strand 457/457
(100 %)
3 diff
(99.4 %id)
AA765920 germinal center B cell MX1.f 3004 to 3462 458 to 1       458/458
(100 %)
11 diff
(97.6 %id)
AI263749 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MX1.f 3006 to 3464 461 to 1       461/461
(100 %)
41 diff
(91.2 %id)
BF737239 bladder_tumor MX1.f 3007 to 3377 375 to 4     Submitted on the opposite strand 372/375
(99 %)
0 diff
(100 %id)
BU736637 eye, Retina Foveal and Macular MX1.f 3009 to 3466 474 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 458/458
(100 %)
0 diff
(100 %id)
AI027390 parathyroid gland, parathyroid tumor MX1.f 3013 to 3462 452 to 1       452/540
(83 %)
21 diff
(96.2 %id)
AI289031 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MX1.f 3019 to 3459 464 to 24   AAA   441/448
(98 %)
0 diff
(100 %id)
AI347761 2 pooled tumors (clear cell type), Kidney MX1.f 3022 to 3467 448 to 3       446/448
(99 %)
0 diff
(100 %id)
AI468773 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MX1.f 3028 to 3464 443 to 1       443/473
(93 %)
10 diff
(97.9 %id)
AI961848 thymus, pooled MX1.f 3030 to 3466 435 to 1       435/435
(100 %)
5 diff
(98.9 %id)
AI382743 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MX1.f 3031 to 3469 435 to 1   tiling clone,   435/435
(100 %)
22 diff
(95.0 %id)
AA954886 colon, colon tumor MX1.f 3033 to 3436 410 to 1       410/451
(90 %)
27 diff
(94.1 %id)
AA970821 colon, colon tumor MX1.f 3034 to 3436 402 to 1       402/402
(100 %)
32 diff
(92.1 %id)
T60073 lung MX1.f 3041 to 3437 400 to 1       400/407
(98 %)
5 diff
(98.8 %id)
N35403 melanocyte MX1.f 3041 to 3466 426 to 1       426/428
(99 %)
3 diff
(99.3 %id)
AI524762 serous papillary carcinoma, high grade, 2pooled tumors, uterus MX1.f 3043 to 3465 461 to 40       422/522
(80 %)
0 diff
(100 %id)
AI347762 2 pooled tumors (clear cell type), Kidney MX1.f 3045 to 3467 427 to 5       423/460
(91 %)
0 diff
(100 %id)
N23975 melanocyte MX1.f 3049 to 3466 421 to 1   fully sequenced,   421/421
(100 %)
3 diff
(99.3 %id)
AA233658 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MX1.f 3049 to 3466 419 to 1       419/419
(100 %)
2 diff
(99.6 %id)
BF925691 nervous_tumor MX1.f 3050 to 3322 278 to 1     Submitted on the opposite strand 278/278
(100 %)
16 diff
(94.3 %id)
AW169347 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus MX1.f 3056 to 3468 413 to 1       413/413
(100 %)
0 diff
(100 %id)
BM673149 eye, optic nerve MX1.f 3056 to 3468 431 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 413/413
(100 %)
0 diff
(100 %id)
AA487959 lung MX1.f 3057 to 3436 386 to 1       386/386
(100 %)
19 diff
(95.1 %id)
AA865246 2 pooled tumors (clear cell type), Kidney MX1.f 3057 to 3457 400 to 1       400/400
(100 %)
27 diff
(93.3 %id)
AW470581 colon, moderately-differentiated adenocarcinoma MX1.f 3057 to 3466 408 to 1       408/408
(100 %)
2 diff
(99.6 %id)
AA587601 ovary, ovary bulk tumor MX1.f 3058 to 3462 404 to 1       404/473
(85 %)
14 diff
(97.1 %id)
W49782 senescent fibroblast MX1.f 3059 to 3464 405 to 1       405/405
(100 %)
1 diff
(99.8 %id)
AA456006 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MX1.f 3062 to 3466 408 to 1       408/474
(86 %)
13 diff
(97.3 %id)
AI968983 brain, four pooled pituitary adenomas MX1.f 3069 to 3465 397 to 1       397/397
(100 %)
0 diff
(100 %id)
AA405416 ovarian tumor, ovary MX1.f 3072 to 3413 1 to 342       342/342
(100 %)
1 diff
(99.8 %id)
AI734036 ovarian tumor, ovary MX1.f 3072 to 3466 1 to 395   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 395/395
(100 %)
2 diff
(99.5 %id)
AA425969 ovarian tumor, ovary MX1.f 3072 to 3464 1 to 393   fully sequenced,   393/393
(100 %)
0 diff
(100 %id)
AI142748 pooled MX1.f 3072 to 3462 391 to 1       391/391
(100 %)
3 diff
(99.3 %id)
AA053117 colon, tumor MX1.f 3076 to 3467 398 to 7       392/398
(98 %)
0 diff
(100 %id)
BI490044 pooled brain, lung, testis MX1.f 3076 to 3466 18 to 408   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 391/408
(95 %)
0 diff
(100 %id)
TI_43960931   MX1.f 3076 to 3466 18 to 408   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 391/408
(95 %)
0 diff
(100 %id)
BP390136 pancreatic islet MX1.f 3077 to 3449 1 to 373     Submitted on the opposite strand 373/373
(100 %)
2 diff
(99.5 %id)
AA402922 ovarian tumor, ovary MX1.f 3080 to 3466 386 to 1       386/386
(100 %)
6 diff
(98.5 %id)
BF953388 nervous_normal MX1.f 3086 to 3286 203 to 2       202/213
(94 %)
0 diff
(100 %id)
AI581987 colon MX1.f 3090 to 3464 375 to 1       375/414
(90 %)
5 diff
(98.8 %id)
AI379185 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MX1.f 3091 to 3468 388 to 11   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 378/378
(100 %)
0 diff
(100 %id)
AW798065 uterus MX1.f 3092 to 3379 1 to 288       288/288
(100 %)
1 diff
(99.7 %id)
BE939393 uterus MX1.f 3092 to 3379 1 to 288       288/288
(100 %)
1 diff
(99.7 %id)
BF985015 uterus MX1.f 3092 to 3379 1 to 288       288/288
(100 %)
1 diff
(99.7 %id)
AU156178 placenta MX1.f 3092 to 3468 376 to 1       376/378
(99 %)
2 diff
(99.5 %id)
BX369916 Placenta Cot 25-normalized MX1.f 3097 to 3464 1 to 368       368/368
(100 %)
3 diff
(99.2 %id)
AA193601.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MX1.f 3098 to 3467 375 to 1     also hits gene SNX4 375/413
(90 %)
10 diff
(97.6 %id)
T99843 liver and spleen MX1.f 3100 to 3455 366 to 1       366/409
(89 %)
14 diff
(96.6 %id)
BF432078 pooled MX1.f 3105 to 3466 361 to 1       361/361
(100 %)
3 diff
(99.2 %id)
N98766 senescent fibroblast MX1.f 3106 to 3413 308 to 1       308/308
(100 %)
0 diff
(100 %id)
AW496798   MX1.f 3116 to 3331 226 to 10       217/226
(96 %)
0 diff
(100 %id)
AI074634 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MX1.f 3128 to 3468 339 to 1       339/339
(100 %)
2 diff
(99.5 %id)
AA151896 colon, tumor MX1.f 3133 to 3440 312 to 1       312/340
(91 %)
12 diff
(96.5 %id)
AA477236 ovarian tumor, ovary MX1.f 3133 to 3468 337 to 1       337/337
(100 %)
7 diff
(98.0 %id)
AI559797 serous papillary carcinoma, high grade, 2pooled tumors, uterus MX1.f 3140 to 3466 342 to 24   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 319/319
(100 %)
16 diff
(95.0 %id)
N25748 melanocyte MX1.f 3142 to 3466 328 to 1       328/437
(75 %)
8 diff
(98.2 %id)
AA370424 Prostate MX1.f 3145 to 3398 1 to 254       254/254
(100 %)
3 diff
(98.9 %id)
T28945 blood, white blood cells MX1.f 3161 to 3466 306 to 1     Submitted on the opposite strand 306/306
(100 %)
1 diff
(99.7 %id)
AA128000 uterus MX1.f 3189 to 3466 277 to 1       277/277
(100 %)
2 diff
(99.3 %id)
AW236287 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood MX1.f 3194 to 3454 261 to 1       261/261
(100 %)
11 diff
(95.8 %id)
AI460116 colon MX1.f 3195 to 3464 270 to 1       270/270
(100 %)
2 diff
(99.3 %id)
BE243368 leukopheresis MX1.f 3203 to 3461 260 to 1       260/260
(100 %)
5 diff
(98.1 %id)
AA004322 liver and spleen MX1.f 3213 to 3439 233 to 1       233/233
(100 %)
21 diff
(91.0 %id)
AW793017 uterus MX1.f 3214 to 3462 249 to 1       249/249
(100 %)
2 diff
(99.2 %id)
AI915251 serous papillary carcinoma, high grade, 2pooled tumors, uterus MX1.f 3224 to 3464 241 to 1       241/289
(83 %)
0 diff
(100 %id)
BF115416 fibrotheoma, ovary MX1.f 3245 to 3466 222 to 1       222/222
(100 %)
2 diff
(99.1 %id)
FN081111 breast carcinoma MX1.f 3246 to 3317 72 to 1     Submitted on the opposite strand 72/73
(98 %)
0 diff
(100 %id)
AJ430453   MX1.f 3253 to 3466 216 to 3       214/216
(99 %)
0 diff
(100 %id)
AI825370 pooled germ cell tumors MX1.f 3267 to 3466 230 to 32       199/230
(86 %)
0 diff
(100 %id)
AI953687 pooled germ cell tumors MX1.f 3267 to 3468 225 to 24   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 202/202
(100 %)
3 diff
(98.6 %id)
AA426260 ovarian tumor, ovary MX1.f 3270 to 3466 197 to 1   fully sequenced,   197/197
(100 %)
0 diff
(100 %id)
AI953746 pooled germ cell tumors MX1.f 3277 to 3464 202 to 15   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 188/188
(100 %)
0 diff
(100 %id)
AI865200 lymph node, lymphoma, follicular mixed small and largecell MX1.f 3362 to 3466 105 to 1       105/105
(100 %)
0 diff
(100 %id)
AA525968 normal prostate, Prostate MX1.f 3371 to 3462 92 to 1       92/92
(100 %)
1 diff
(99.0 %id)
FN090715 breast carcinoma MX1.f 3372 to 3464 1 to 91       91/93
(97 %)
3 diff
(96.8 %id)
FN162855 breast carcinoma MX1.f 3399 to 3466 69 to 2     Submitted on the opposite strand 68/69
(98 %)
0 diff
(100 %id)
DA950315 Spleen MX1.g 1 to 572 2 to 573   tiling clone, capped   572/572
(100 %)
1 diff
(99.9 %id)
AW371607 breast MX1.g 489 to 713 21 to 247   tiling clone,   227/249
(91 %)
10 diff
(96.0 %id)
AW390099 stomach MX1.h 1 to 455 467 to 13   tiling clone,   455/673
(67 %)
4 diff
(99.5 %id)
AA421890 ovarian tumor, ovary MX1.h 222 to 566 1 to 352       352/352
(100 %)
27 diff
(92.4 %id)
AA233688 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MX1.h 277 to 708 1 to 432   tiling clone,   432/432
(100 %)
3 diff
(99.4 %id)
F05704 brain, total brain MX1.h 325 to 553 1 to 229       229/229
(100 %)
0 diff
(100 %id)
BQ320071 colon MX1.h 576 to 694 121 to 1   tiling clone,   121/121
(100 %)
5 diff
(95.9 %id)
AA233653 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus MX1.h 940 to 1347 407 to 1   tiling clone,   407/407
(100 %)
1 diff
(99.8 %id)
AA411349 ovarian tumor, ovary MX1.h 956 to 1343 390 to 1   tiling clone,   390/409
(95 %)
29 diff
(93.0 %id)
F01957 brain, total brain MX1.h 1094 to 1347 254 to 1       254/254
(100 %)
2 diff
(99.3 %id)
BF836392 head_neck MX1.i 1 to 428 1 to 428   tiling clone,   428/428
(100 %)
11 diff
(97.5 %id)
CF619276 Pooled Chondrosarcoma Tumor cells MX1.i 404 to 933 1 to 536       536/1091
(49 %)
19 diff
(98.3 %id)
CF780779 Pooled Chondrosarcoma Tumor cells MX1.i 405 to 1135 1 to 729   tiling clone,   729/936
(77 %)
15 diff
(98.4 %id)
AA287896 germinal center B cell MX1.i 951 to 1358 1 to 408   tiling clone,   408/408
(100 %)
1 diff
(99.8 %id)
BQ929337 leiomyosarcoma, uterus MX1.i 1238 to 1960 9 to 731   tiling clone,   723/774
(93 %)
4 diff
(99.5 %id)
TI_227712538   MX1.i 1436 to 2283 923 to 89   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 835/946
(88 %)
18 diff
(98.1 %id)
CD366904 Alveolar Macrophage, lung MX1.i 1570 to 2283 729 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 713/713
(100 %)
2 diff
(99.8 %id)
AW969217   MX1.i 2212 to 2783 572 to 1   tiling clone, Submitted on the opposite strand 572/573
(99 %)
5 diff
(99.2 %id)
AA521365 germinal center B cell MX1.i 2247 to 2773 517 to 1       517/523
(98 %)
24 diff
(95.5 %id)
AA287544 germinal center B cell MX1.i 2383 to 2786 407 to 4   tiling clone,   404/407
(99 %)
0 diff
(100 %id)
AW059878   MX1.i 2645 to 2784 140 to 1   tiling clone,   140/140
(100 %)
0 diff
(100 %id)
N41337 placenta MX1.j 1 to 516 1 to 516   tiling clone,   516/516
(100 %)
3 diff
(99.5 %id)
N30725 placenta MX1.j 812 to 1248 447 to 4   tiling clone,   444/449
(98 %)
0 diff
(100 %id)
BU502422 mixed (pool of 40 RNAs) MX1.k 1 to 747 6 to 758   tiling clone,   758/758
(100 %)
15 diff
(98.1 %id)
BQ722469 sympathetic trunk MX1.k 9 to 861 1 to 859 K119* tiling clone,   859/912
(94 %)
33 diff
(96.4 %id)
DA961420 Spleen MX1.k 27 to 594 2 to 569   tiling clone, capped   568/568
(100 %)
2 diff
(99.7 %id)
DA385020 thalamus MX1.k 242 to 814 2 to 574   tiling clone, capped   573/573
(100 %)
1 diff
(99.9 %id)
CR982304 T-Lymphocytes MX1.l 1 to 820 4 to 824 L6X E7R N8K Q9S I10N ... tiling clone,   824/824
(100 %)
4 diff
(99.6 %id)
DB120136 thymus MX1.m 1 to 559 2 to 560 exact tiling clone, capped   559/559
(100 %)
0 diff
(100 %id)
DA358764 subthalamic nucleus MX1.n 1 to 575 2 to 577 S41R C45V K46Q R47K Y49I ... tiling clone, capped   576/576
(100 %)
2 diff
(99.7 %id)
AL120322 amygdala MX1.o-u 1 to 411 1 to 411 Q29R T32A V43I S55G D56G ... tiling clone,   411/411
(100 %)
12 diff
(97.1 %id)
BM153296 leukopheresis MX1.o-u 293 to 824 531 to 1   tiling clone,   531/531
(100 %)
26 diff
(95.2 %id)
BM150442 leukopheresis MX1.o-u 389 to 824 436 to 1       436/436
(100 %)
7 diff
(98.4 %id)
DB126308 thymus MX1.o-u 406 to 979 2 to 575   tiling clone, capped   574/574
(100 %)
0 diff
(100 %id)
BQ028946 Bone, Subchondral Bone MX1.o-u 675 to 1138 481 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (14/17 A in genome downstream of last aligned base) 463/470
(98 %)
16 diff
(96.6 %id)
DB242162 stomach, tumor tissue MX1.p 1 to 558 2 to 559 A7T tiling clone, capped   558/558
(100 %)
1 diff
(99.9 %id)
DA042009 bladder MX1.p 38 to 606 2 to 570 exact capped   569/569
(100 %)
0 diff
(100 %id)
BE616930 adenocarcinoma, colon MX1.p 69 to 780 1 to 722 T12S H19V D20T G21T T23A ...     722/723
(99 %)
46 diff
(93.7 %id)
BG700598 brain, hippocampus MX1.p 75 to 744 1 to 671 F60Y     671/671
(100 %)
16 diff
(97.7 %id)
DA011736 adrenal gland MX1.p 81 to 648 2 to 569 exact tiling clone, capped   568/568
(100 %)
0 diff
(100 %id)
DB169559 kidney, tumor tissue MX1.p 81 to 582 2 to 503 exact capped   502/502
(100 %)
0 diff
(100 %id)
DA302331 hippocampus MX1.p 111 to 583 2 to 475   capped   474/474
(100 %)
1 diff
(99.8 %id)
DA448294 tongue, tumor tissue MX1.p 111 to 625 2 to 515   capped   514/520
(98 %)
5 diff
(99.1 %id)
DA703205   MX1.p 111 to 582 2 to 473   capped   472/472
(100 %)
0 diff
(100 %id)
DB134114 thymus MX1.p 111 to 655 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
BI825015 pooled brain, lung, testis MX1.p 185 to 818 17 to 650   tiling clone,   634/651
(97 %)
2 diff
(99.7 %id)
TI_57201818   MX1.p 185 to 818 17 to 650       634/651
(97 %)
2 diff
(99.7 %id)
CD709587 normal nasopharynx MX1.q -11 to 376 24 to 410 S15R F76P tiling clone,   387/410
(94 %)
3 diff
(99.3 %id)
TI_57180912   MX1.r 1 to 753 68 to 821 S34R tiling clone,   754/821
(91 %)
6 diff
(99.3 %id)
BI768644 pooled lung and spleen MX1.r 2 to 753 1 to 753 S34R tiling clone,   753/753
(100 %)
6 diff
(99.3 %id)
CB250613 Human Lung Epithelial cells, lung MX1.r 265 to 963 717 to 19   AAA   699/699
(100 %)
3 diff
(99.6 %id)
CA422865 cell lines, Chondrosarcoma MX1.r 298 to 963 683 to 19   tiling clone, AAA   665/665
(100 %)
1 diff
(99.9 %id)
AW571514 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors MX1.r 531 to 964 434 to 1   tiling clone,   434/434
(100 %)
1 diff
(99.8 %id)
AI568920 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus MX1.r 540 to 963 424 to 1       424/424
(100 %)
1 diff
(99.8 %id)
AI284915 adenocarcinoma, colon MX1.r 542 to 960 424 to 6       419/424
(98 %)
0 diff
(100 %id)
AI216306 pooled MX1.r 592 to 964 379 to 7       373/379
(98 %)
0 diff
(100 %id)
BQ712353 Spleen MX1.s 1 to 898 5 to 905 G102X R103E E104G G105R S106F ... tiling clone,   905/985
(91 %)
52 diff
(94.8 %id)
BQ709072 Spleen MX1.s 4 to 918 1 to 928 G87X     928/994
(93 %)
39 diff
(96.1 %id)
BC052255 Spleen MX1.s 7 to 3191 1 to 3187 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 3187/3187
(100 %)
6 diff
(99.9 %id)
BQ708225 Spleen MX1.s 8 to 860 1 to 857 exact available from MGC,   857/918
(93 %)
13 diff
(98.6 %id)
AW797919 uterus MX1.s 1442 to 1571 144 to 15       130/144
(90 %)
0 diff
(100 %id)
BM803446 embryonal carcinoma, cell line, testis MX1.t 1 to 458 34 to 491 L19V tiling clone,   458/1223
(37 %)
7 diff
(99.5 %id)
BQ215689 melanotic melanoma, skin MX1.u 1 to 887 1 to 899 G36A tiling clone,   899/899
(100 %)
16 diff
(98.3 %id)
DA955269 Spleen MX1.va 1 to 569 2 to 571 exact tiling clone, capped   570/570
(100 %)
1 diff
(99.9 %id)
CB151486 cervix, Uterine MX1.va 211 to 726 1 to 516 Q44Y     516/516
(100 %)
2 diff
(99.7 %id)
DA045409 bladder MX1.va 310 to 881 2 to 573   tiling clone, capped   572/572
(100 %)
1 diff
(99.9 %id)
BI547040 brain, hippocampus MX1.vb 1 to 656 1 to 664 K46E K54N L55S M57C L58* tiling clone,   664/793
(83 %)
19 diff
(97.7 %id)
TI_44167720   MX1.vb 6 to 656 131 to 789 K46E K54N L55S M57C L58* tiling clone,   659/918
(71 %)
15 diff
(98.4 %id)
DB464630 hippocampus MX1.vb 8 to 461 1 to 458 A7G H13T P14R P16H R20Q ...     458/458
(100 %)
9 diff
(98.1 %id)
DA125149 cerebellum MX1.vb 21 to 556 2 to 538 S41R C45V K46Q R47K Y49I ... tiling clone, capped   537/539
(99 %)
4 diff
(99.3 %id)
DA414055 thalamus MX1.vb 21 to 580 2 to 562 S41R C45V K46Q R47K Y49I ... tiling clone, capped   561/561
(100 %)
2 diff
(99.7 %id)
DA370429 thalamus MX1.vc 1 to 488 2 to 490 V31G Y32V N33* tiling clone, capped   489/489
(100 %)
1 diff
(99.8 %id)
DA111493 cerebellum MX1.vc 40 to 604 2 to 566 exact tiling clone, capped   565/565
(100 %)
0 diff
(100 %id)
BP287660 lung MX1.vd 1 to 585 1 to 582 exact tiling clone,   582/582
(100 %)
9 diff
(98.5 %id)
DA189197 amygdala MX1.ve 1 to 577 2 to 578 exact tiling clone, capped   577/577
(100 %)
0 diff
(100 %id)
DA726913   MX1.vf 1 to 555 2 to 556 exact tiling clone, capped   555/555
(100 %)
0 diff
(100 %id)
DA398706 thalamus MX1.vg 1 to 553 2 to 554 exact tiling clone, capped   553/553
(100 %)
2 diff
(99.7 %id)
AV703204 adrenal gland Gene MX1, variant not shown         Suspected internal deletion, this clone was ignored    
AK093008 Spleen Gene MX1, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored    
AX747854   Gene MX1, variant not shown         Suspected internal deletion, this clone was ignored    
BF769202 epid_tumor Gene MX1, variant not shown         Submitted on the opposite strand    
DB310235 substantia nigra Gene MX1, variant not shown         This clone was ignored    
DA345826 substantia nigra Gene MX1, variant not shown       capped This clone was ignored    
DA381252 thalamus Gene MX1, variant not shown       capped This clone was ignored    
BP227098   Gene MX1, variant not shown         Suspected internal deletion, this clone was ignored    
AA284805 ovarian tumor, ovary Gene MX1, variant not shown         This clone was ignored    
AA284852 ovarian tumor, ovary Gene MX1, variant not shown         This clone was ignored    
AA477751 ovarian tumor, ovary Gene MX1, variant not shown         This clone was ignored    
AA477857 ovarian tumor, ovary Gene MX1, variant not shown         This clone was ignored    
AI935600 Kidney Gene MX1, variant not shown              
BF971481 leiomyosarcoma cell line, uterus Gene MX1, variant not shown         This clone was ignored    
BG339205 leiomyosarcoma cell line, uterus Gene MX1, variant not shown         This clone was ignored    
BG339685 leiomyosarcoma cell line, uterus Gene MX1, variant not shown         This clone was ignored    
DA873316 Prostate Gene MX1, variant not shown       capped      
DB330034 Prostate Gene MX1, variant not shown              
DA920614 small intestine Gene MX1, variant not shown       capped This clone was ignored    
DB331908 small intestine Gene MX1, variant not shown         This clone was ignored    
DB128872 thymus Gene MX1, variant not shown       capped This clone was ignored    
DB344443 thymus Gene MX1, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o-u, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf, .vg Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI